European Regulatory Round-Up: New Faces; Revised Guidances; More Cost Controls
Executive Summary
A new chairman will take the helm of Germany's G-BA panel at a pivotal time for AMNOG implementation; the European Medicines Agency issues guidances in oncology drug development and genotoxicity; more regulatory updates.